Drug Profile
Modafinil oral - D&A Pharma
Alternative Names: ASBLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator D&A Pharma
- Class Benzhydryl compounds; Sleep disorder therapies; Small molecules
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Central nervous system stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cocaine-related disorders
Most Recent Events
- 28 Mar 2019 No recent reports of development identified for phase-I development in Cocaine-abuse in France (PO)
- 12 May 2016 Chemical structure information added
- 15 Feb 2016 Phase-I clinical trials in Cocaine abuse in France (PO)